Table 3.
Complications and Long-term Outcomes
| Variable | Total (n = 146) |
TMA success (n = 105) |
Higher-level amputation (n = 41) |
P |
|---|---|---|---|---|
| Postoperative infection | 26 (17.8%) | 10 (9.5%) | 16 (39.0%) | <0.001 |
| Wound dehiscence | 65 (44.5%) | 42 (40%) | 23 (56.1%) | 0.079 |
| Unplanned return to operating room | 62 (42.5%) | 28 (26.7%) | 34 (82.9%) | <0.001 |
| Hematoma | 6 (4.1%) | 4 (3.8%) | 2 (4.9%) | 0.673 |
| Re-ulceration at TMA site | 55 (37.7%) | 38 (36.2%) | 17 (41.5%) | 0.555 |
| Higher-level amputation Lisfranc amputation Chopart amputation Below-knee amputation |
41 (28.1%) 13 9 18 |
—- | —- | —- |
| Median time to amputation (IQR; mo) | — | — | 1.8 (0.6, 6.2) | —- |
| Limb Salvage | 128 (87.7%) | 105 (100%) | 23 (56.1%) | <0.001 |
| Ambulatory | 121 (82.9%) | 90 (85.7%) | 31 (75.6%) | 0.145 |
| Deceased | 43 (29.5%) | 29 (27.6%) | 14 (34.1%) | 0.437 |
| Follow-up duration (mo) | 23.2 + 21.5 | 22.8 + 22.1 | 24.2 + 20.1 | 0.496 |
IQR, interquartile range.
P-values in boldface signify statistical significance.